197 related articles for article (PubMed ID: 15319430)
1. Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors.
Wüller S; Wiesner B; Löffler A; Furkert J; Krause G; Hermosilla R; Schaefer M; Schülein R; Rosenthal W; Oksche A
J Biol Chem; 2004 Nov; 279(45):47254-63. PubMed ID: 15319430
[TBL] [Abstract][Full Text] [Related]
2. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Robben JH; Sze M; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
[TBL] [Abstract][Full Text] [Related]
3. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R
Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.
Mouillac B; Mendre C
Pharmacol Res; 2014 May; 83():74-8. PubMed ID: 24239889
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
Morello JP; Salahpour A; Laperrière A; Bernier V; Arthus MF; Lonergan M; Petäjä-Repo U; Angers S; Morin D; Bichet DG; Bouvier M
J Clin Invest; 2000 Apr; 105(7):887-95. PubMed ID: 10749568
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pharmacochaperone-mediated rescue of mutant V2 receptor proteins.
Erdem Tuncdemir B; Mergen H; Saglar Ozer E
Eur J Pharmacol; 2019 Dec; 865():172803. PubMed ID: 31738937
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor.
Hawtin SR
J Biol Chem; 2006 May; 281(21):14604-14. PubMed ID: 16565083
[TBL] [Abstract][Full Text] [Related]
8. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
Tan CM; Nickols HH; Limbird LE
J Biol Chem; 2003 Sep; 278(37):35678-86. PubMed ID: 12824183
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
10. Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism.
Robben JH; Sze M; Knoers NV; Deen PM
Mol Biol Cell; 2006 Jan; 17(1):379-86. PubMed ID: 16267275
[TBL] [Abstract][Full Text] [Related]
11. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
Birnbaumer M; Gilbert S; Rosenthal W
Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
[TBL] [Abstract][Full Text] [Related]
12. Use of Kikume green-red fusions to study the influence of pharmacological chaperones on trafficking of G protein-coupled receptors.
Ridelis I; Schmidt A; Teichmann A; Furkert J; Wiesner B; Schülein R
FEBS Lett; 2012 Mar; 586(6):784-91. PubMed ID: 22306118
[TBL] [Abstract][Full Text] [Related]
13. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists.
Robben JH; Kortenoeven ML; Sze M; Yae C; Milligan G; Oorschot VM; Klumperman J; Knoers NV; Deen PM
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12195-200. PubMed ID: 19587238
[TBL] [Abstract][Full Text] [Related]
14. Rescue of a nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutant by cell-penetrating peptides.
Oueslati M; Hermosilla R; Schönenberger E; Oorschot V; Beyermann M; Wiesner B; Schmidt A; Klumperman J; Rosenthal W; Schülein R
J Biol Chem; 2007 Jul; 282(28):20676-85. PubMed ID: 17491025
[TBL] [Abstract][Full Text] [Related]
15. Novel down-regulatory mechanism of the surface expression of the vasopressin V2 receptor by an alternative splice receptor variant.
Sarmiento JM; Añazco CC; Campos DM; Prado GN; Navarro J; González CB
J Biol Chem; 2004 Nov; 279(45):47017-23. PubMed ID: 15355989
[TBL] [Abstract][Full Text] [Related]
16. A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.
Schülein R; Hermosilla R; Oksche A; Dehe M; Wiesner B; Krause G; Rosenthal W
Mol Pharmacol; 1998 Sep; 54(3):525-35. PubMed ID: 9730911
[TBL] [Abstract][Full Text] [Related]
17. Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
Krause G; Hermosilla R; Oksche A; Rutz C; Rosenthal W; Schülein R
Mol Pharmacol; 2000 Feb; 57(2):232-42. PubMed ID: 10648632
[TBL] [Abstract][Full Text] [Related]
18. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.
Morello JP; Salahpour A; Petäjä-Repo UE; Laperrière A; Lonergan M; Arthus MF; Nabi IR; Bichet DG; Bouvier M
Biochemistry; 2001 Jun; 40(23):6766-75. PubMed ID: 11389590
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium.
Nickols HH; Shah VN; Chazin WJ; Limbird LE
J Biol Chem; 2004 Nov; 279(45):46969-80. PubMed ID: 15319442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
